Results 131 to 140 of about 45,546 (194)

Venetoclax plus azacitidine, low-dose cytarabine, aclarubicin, and G-CSF (VA-CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single-arm Phase II clinical trial. [PDF]

Hemasphere
Li X, Zhang Q, Li X, Liu L, Shen Y, Li Y, Peng L, Zhou C, Qiu C, Yuan Z, Hou S, Wang Y, Zhang L, Li J, Zhao L, Tang Q, Chen Z, Feng J, Zhang X, Bao G, Zhang K, Zhang R, Li S, Chen Y, Rao J, Dong Y, Zhang D, Wang Y, Li A, Ye X, Lei L, Chen J, Xu S, Jin Y, Zheng C, Liang Y, Wang S.   +36 more
europepmc   +1 more source

Patterns and Outcomes of Recurrence in Pediatric Langerhans Cell Histiocytosis. [PDF]

J Hematol
Bhattacharya S, Singh A, Radhakrishnan N, Tulsiyan A, Pandharipande A.   +4 more
europepmc   +1 more source

Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications. [PDF]

Cancers (Basel)
Konstantinidis I, Tsokkou S, Makedou K, Gavriilaki E, Delis G, Papamitsou T.   +5 more
europepmc   +1 more source

Adult T-cell Leukemia/Lymphoma in Japan: Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs. [PDF]

J Health Econ Outcomes Res
Dharmani C, Islam Z, Qu P, Jiang Z, Wang J, Li L, Tao Y, Song L.   +7 more
europepmc   +1 more source

Acute Myeloid Leukaemia Driven by Rare HNRNPH1::ERG Fusion Gene in an Adult, With Distinct Transcripts Detected by RNASeq at Diagnosis and Relapse: A Case Report. [PDF]

EJHaem
Al-Yousuf H, Prieto P, Baker R, Clesham K, Xu K, Wilson A, Zheng J, Gupta R, Sellar R, O'Nions J.   +9 more
europepmc   +1 more source

Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia. [PDF]

Nat Commun
NajafPanah MJ, Stevens AM, Krueger MJ, Rochette M, Sandhu S, Kim L, Chiu HS, Epps J, Somvanshi S, Zorman B, Rodriguez Martinez M, Rapsomaniki M, Unger S, Becher B, Yi JS, Man TK, Redell MS, Sumazin P.   +17 more
europepmc   +1 more source

Sequential emergence of FLT3-ITD and BCR::ABL1 during disease progression in relapsed acute myeloid leukemia. [PDF]

Ann Hematol
Irifune H, Semba Y, Uehara Y, Ohta T, Sugio Y, Akashi K, Maeda T, Ohno Y.   +7 more
europepmc   +1 more source

Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. [PDF]

Blood Adv
Lee-Miller CA, Kairalla JA, Hibbitts E, Winick NJ, Rabin KR, Angiolillo A, Schore RJ, Salzer WL, Burke MJ, Loh ML, Raetz EA, Hunger SP, Devidas M, Teachey DT, Gupta S, McNeer JL.   +15 more
europepmc   +1 more source